Direktorat Registrasi ObatValid

RANITIDINE HYDROCHLORIDE

BPOM Number: GKL9220911517A1
Approved: 21 November 2024
Expiry: 10 December 2027
Form: TABLET SALUT SELAPUT;

About This Registration

RANITIDINE HYDROCHLORIDE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL9220911517A1. Its current registration status is Valid, with the licence valid until 10 December 2027. The product is registered to INDOFARMA - INDONESIA. BPOM first approved this registration in November 2023. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 10 STRIP @ 10 TABLET SALUT SELAPUT
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

INDOFARMA - INDONESIA
KAB. BEKASI
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

INDOFARMA - INDONESIA
KAB. BEKASI
primary
View profile →

Ingredients (1)

RANITIDINE HYDROCHLORIDE

Market Intelligence

Owner Portfolio: INDOFARMA - INDONESIA holds 195 BPOM registrations
Manufacturer Scale: INDOFARMA - INDONESIA produces 195 registered products
Registration Age: Registered for 2 years, 10 months

FDA Cross-Reference

via openFDA

Generic Name: RANITIDINE
Product Type: HUMAN OTC DRUG
Route of Administration: ORAL
Purpose: Purpose Acid reducer

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?